Endorepellin In Vivo: Targeting the Tumor Vasculature and Retarding Cancer Growth and Metabolism

Abstract

Our results provide support for the hypothesis that endorepellin is an effective antitumor vasculature agent that could be used as a therapeutic modality to combat cancer.